Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,256 | 5,578 | 9,432 | 13,783 | 17,368 |
| Marketable Securities | N/A | N/A | N/A | 441 | 530 |
| Receivables | 85 | 161 | 484 | 1,882 | 1,716 |
| Other current assets | 32 | 61 | 139 | 139 | 191 |
| TOTAL | $9,968 | $6,535 | $10,698 | $16,917 | $20,984 |
| Non-Current Assets | |||||
| PPE Net | 3,347 | 3,528 | 3,799 | 4,076 | 5,997 |
| Intangibles | 56,551 | 56,573 | 56,595 | 56,617 | 56,639 |
| Other Non-Current Assets | 4,854 | 4,337 | 3,800 | 3,977 | 3,920 |
| TOTAL | $64,752 | $64,438 | $64,194 | $64,670 | $66,556 |
| Total Assets | $74,720 | $70,973 | $74,892 | $81,587 | $87,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,051 | 908 | 953 | 1,136 | 875 |
| Accrued Expenses | 5,118 | 6,598 | 3,217 | 6,087 | 5,920 |
| Other current liabilities | N/A | N/A | 2,314 | N/A | N/A |
| TOTAL | $7,198 | $8,327 | $7,194 | $8,033 | $7,667 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44,819 | 51,058 | 47,230 | 35,992 | 36,273 |
| TOTAL | $44,819 | $51,058 | $47,230 | $35,992 | $36,273 |
| Total Liabilities | $52,017 | $59,385 | $54,424 | $44,025 | $43,940 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,368 | 13,365 | 8,273 | 8,261 | 8,241 |
| Common Shares | 326,201 | 310,553 | 310,295 | 309,995 | 309,535 |
| Retained earnings | -303,535 | -299,005 | -289,876 | -272,465 | -265,976 |
| Other shareholders' equity | 37 | 40 | 49 | 32 | 41 |
| TOTAL | $22,703 | $11,588 | $20,468 | $37,562 | $43,600 |
| Total Liabilities And Equity | $74,720 | $70,973 | $74,892 | $81,587 | $87,540 |